Browsing Tag
NK Cell Therapy
3 posts
How AlloNK could challenge autologous CAR-T approaches in difficult autoimmune diseases
Can AlloNK challenge autoimmune CAR-T therapies? Explore what Artiva Biotherapeutics, Inc.’s latest data means for the future of cell therapy.
How SC-dosed NK cell engagers like GTB-5550 could disrupt cancer care delivery models
GT Biopharma’s GTB-5550 receives FDA clearance with subcutaneous delivery. See how this trial could shift NK immunotherapy into outpatient cancer care.
Chimeric Therapeutics announces breakthrough AML response with CHM CORE-NK in Phase 1B trial
Chimeric Therapeutics has reported a significant milestone in its ongoing clinical trials, wherein a patient diagnosed with Acute…